Action ILMN ILLUMINA, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Illumina, Inc.

Actions

ILMN

US4523271090

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 06/06/2024 		Varia. 5j. Varia. 1 janv.
114,7 USD +7,42 % Graphique intraday de Illumina, Inc. +13,52 % -17,61 %
06/06 ILLUMINA, INC. : TD Cowen n'est pas inspiré par le dossier ZM
05/06 ILLUMINA, INC. : Nephron Research moins négatif, passe à neutre ZM

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost
PR
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares
PR
Illumina appoints Everett Cunningham Chief Commercial Officer
PR
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO
AQ
Illumina releases 2023 Corporate Social Responsibility Report
PR
Anna Richo joins Illumina's Board of Directors
PR
Illumina To Webcast Upcoming Investor Conference
PR
Devyser Diagnostics AB publishes quarterly report for the period January to March 2024
AQ
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL
PR
Illumina to Webcast Upcoming Investor Conference
AQ
Illumina To Webcast Upcoming Investor Conference
PR
Illumina : First Quarter 2024 Prepared Remarks
PU
Illumina: Q1 Earnings Snapshot
AQ
Illumina : 2024 Assurance Statement
PU
Illumina's planned divestment of GRAIL approved by the European Commission
AQ
Illumina's planned divestment of GRAIL approved by the European Commission
PR
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer
PR
Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024
PR
GRAIL Presents New Data on Galleri and Its Methylation Platform at the Annual American Association for Cancer Research Meeting
AQ
Devyser Diagnostics AB publishes year-end report for January to December 2023
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ILMN
  4. Actualités Illumina, Inc.
  5. Communiqués